The global embolic protection devices market size is expected to reach USD 1.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.7% from 2024 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.

Access the Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion Devices, Proximal Occlusion Devices, Distal Filters), By Application, By Region, And Segment Forecasts, 2024 - 2030

Embolic Protection Devices Market Report Highlights

·        Distal filter devices segment emerged as the largest segment owing to high demand for these devices

·        Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders

·        North America led the global embolic protection devices market with the largest share in 2023 and is likely to maintain this trend over the estimated period

·        Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region

·        The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base

Key Embolic Protection Devices Company Insights

Some of the key companies in the embolic protection devices market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, Medtronic and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry.

Edwards Lifesciences Corporation specializes in manufacturing and development of devices for structural heart diseases and critical care monitoring.

Order your free sample copy of “Embolic Protection Devices Market Report 2024 - 2030, published by Grand View Research

Key Embolic Protection Devices Companies:

The following are the leading companies in the embolic protection devices market. These companies collectively hold the largest market share and dictate industry trends.

·        Boston Scientific Corporation

·        Edwards Lifesciences Corporation.

·        Abbott.

·        Medtronic

·        Cardinal Health.

·        Innovative Cardiovascular Solutions, LLC

·        Transverse Medical, Inc.

·        W. L. Gore & Associates, Inc.

Recent Developments

·        In April 2024, Emboline, Inc., announced the acquisition of SWAT Medical’s Intellectual Property Portfolio of embolic protection. This acquisition is expected to expand Emboline’s existing portfolio of platform technologies to reduce the risk of stroke caused due to the release of embolic debris in the bloodstream during procedures such as Transcatheter Aortic Valve Replacement (TAVR).

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com